217 related articles for article (PubMed ID: 21330007)
1. Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction.
O'Connell K; Boo TW; Keady D; Niriain U; O'Donovan D; Commane M; Faherty C; Cormican M
J Hosp Infect; 2011 Apr; 77(4):338-42. PubMed ID: 21330007
[TBL] [Abstract][Full Text] [Related]
2. Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit.
Abadesso C; Almeida HI; Virella D; Carreiro MH; Machado MC
J Hosp Infect; 2004 Sep; 58(1):38-41. PubMed ID: 15350712
[TBL] [Abstract][Full Text] [Related]
3. Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units.
Kurz H; Herbich K; Janata O; Sterniste W; Bauer K
J Hosp Infect; 2008 Nov; 70(3):246-52. PubMed ID: 18799241
[TBL] [Abstract][Full Text] [Related]
4. The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit.
Cox RA; Rao P; Brandon-Cox C
J Hosp Infect; 2001 Jul; 48(3):186-92. PubMed ID: 11439005
[TBL] [Abstract][Full Text] [Related]
5. Use of palivizumab with other infection control measures to control respiratory syncytial virus outbreaks in neonatal care units.
Hammoud MS; Al-Taiar A; Raina A; Elsori D; Al-Qabandi S; Al-Essa M
J Trop Pediatr; 2016 Oct; 62(5):409-14. PubMed ID: 27118823
[TBL] [Abstract][Full Text] [Related]
6. Palivizumab prophylaxis during nosocomial outbreaks of respiratory syncytial virus in a neonatal intensive care unit: predicting effectiveness with an artificial neural network model.
Saadah LM; Chedid FD; Sohail MR; Nazzal YM; Al Kaabi MR; Rahmani AY
Pharmacotherapy; 2014 Mar; 34(3):251-9. PubMed ID: 23897635
[TBL] [Abstract][Full Text] [Related]
7. [Outbreak of respiratory syncytial virus at a neonatal intensive care unit in Mexico City].
Murguía-de Sierra T; Casasola-Flores J; Rosales-Urbán S; Nava-Ibarra V; Navarrete-Navarro S
Bol Med Hosp Infant Mex; 1993 Oct; 50(10):709-16. PubMed ID: 8216868
[TBL] [Abstract][Full Text] [Related]
8. Nosocomial transmission of respiratory syncytial virus in neonatal intensive care and intermediate care units: a prospective epidemiologic study.
Berger A; Obwegeser E; Aberle SW; Langgartner M; Popow-Kraupp T
Pediatr Infect Dis J; 2010 Jul; 29(7):669-70. PubMed ID: 20305582
[TBL] [Abstract][Full Text] [Related]
9. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
[TBL] [Abstract][Full Text] [Related]
10. Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.
Henckel E; Luthander J; Berggren E; Kapadia H; Naver L; Norman M; Bennet R; Eriksson M
Pediatr Infect Dis J; 2004 Jan; 23(1):27-31. PubMed ID: 14743042
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus prophylaxis in a tertiary care neonatal intensive care unit.
Katz BZ; Sullivan C
Pediatr Infect Dis J; 2009 Sep; 28(9):842-4. PubMed ID: 19636282
[TBL] [Abstract][Full Text] [Related]
12. Palivizumab outcomes registry data from Spain: Infección Respiratoria Infantil por Virus Respiratorio Sincitial (IRIS) Study Group.
Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S55-7; discussion S57. PubMed ID: 12671453
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial Respiratory Viral Infection in the Neonatal Intensive Care Unit.
Vain NE
Am J Perinatol; 2020 Sep; 37(S 02):S22-S25. PubMed ID: 32898879
[TBL] [Abstract][Full Text] [Related]
14. Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit.
Jalal H; Bibby DF; Bennett J; Sampson RE; Brink NS; MacKinnon S; Tedder RS; Ward KN
J Clin Microbiol; 2007 Jun; 45(6):1690-6. PubMed ID: 17392447
[TBL] [Abstract][Full Text] [Related]
15. Palivizumab use during respiratory syncytial virus outbreak in the neonatal intensive care unit.
Alan S; Okulu E; Kiliç A; Atasay B; Arsan S
J Hosp Infect; 2012 Aug; 81(4):292-3. PubMed ID: 22727129
[No Abstract] [Full Text] [Related]
16. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
Pedraz C; Carbonell-Estrany X; Figueras-Aloy J; Quero J;
Pediatr Infect Dis J; 2003 Sep; 22(9):823-7. PubMed ID: 14506376
[TBL] [Abstract][Full Text] [Related]
17. Rapid testing for respiratory syncytial virus in a paediatric emergency department: benefits for infection control and bed management.
Mills JM; Harper J; Broomfield D; Templeton KE
J Hosp Infect; 2011 Mar; 77(3):248-51. PubMed ID: 21277648
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus outbreak defined by rapid screening in a neonatal intensive care unit.
Dizdar EA; Aydemir C; Erdeve O; Sari FN; Oguz S; Uras N; Dilmen U
J Hosp Infect; 2010 Aug; 75(4):292-4. PubMed ID: 20299133
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial respiratory syncytial virus infections in the palivizumab-prophylaxis era with implications regarding high-risk infants.
Ashkenazi-Hoffnung L; Dotan M; Livni G; Amir J; Bilavsky E
Am J Infect Control; 2014 Sep; 42(9):991-5. PubMed ID: 25179332
[TBL] [Abstract][Full Text] [Related]
20. An unusual respiratory syncytial virus nosocomial outbreak in an adult psychiatry ward.
Huang FL; Chen PY; Shi ZY; Chan CH; Huang SK
Jpn J Infect Dis; 2009 Jan; 62(1):61-2. PubMed ID: 19168963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
